home / stock / bvnkf / bvnkf short
Short Information | Bavarian Nordic R/I Ord (OTCMKTS:BVNKF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,897 |
Total Actual Volume | 9,828 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 14 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 395 |
Average Short Percentage | 72.49% |
Is there a BVNKF Short Squeeze or Breakout about to happen?
See the BVNKF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-17-2024 | $0 | $21.2 | $0 | $0 | 1,003 | 1,000 | 99.7% |
05-10-2024 | $0 | $21.2 | $0 | $0 | 10 | 10 | 100% |
04-01-2024 | $22.6 | $22.6 | $22.6 | $22.6 | 106 | 100 | 94.34% |
02-23-2024 | $24.91 | $24.91 | $24.91 | $24.91 | 118 | 15 | 12.71% |
02-09-2024 | $22 | $21.8685 | $22.56 | $21.8685 | 700 | 100 | 14.29% |
01-29-2024 | $21.83 | $21.83 | $21.83 | $21.83 | 106 | 5 | 4.72% |
01-18-2024 | $0 | $24.73 | $0 | $0 | 1 | 1 | 100% |
12-28-2023 | $27 | $27 | $27 | $27 | 1,035 | 1,000 | 96.62% |
12-26-2023 | $26 | $26 | $26 | $26 | 1,000 | 1,000 | 100% |
12-01-2023 | $25.07 | $22.71 | $25.07 | $22.71 | 660 | 550 | 83.33% |
10-27-2023 | $18 | $18 | $18 | $18 | 1,000 | 1,000 | 100% |
10-23-2023 | $19.28 | $19.26 | $19.28 | $19.26 | 410 | 404 | 98.54% |
09-13-2023 | $20 | $21.31 | $21.31 | $20 | 950 | 950 | 100% |
08-04-2023 | $20.97 | $20.97 | $20.97 | $20.97 | 125 | 20 | 16% |
06-13-2023 | $31.95 | $32.05 | $32.05 | $31.95 | 503 | 100 | 19.88% |
06-12-2023 | $31.1 | $31.1 | $31.1 | $31.1 | 205 | 142 | 69.27% |
06-07-2023 | $30 | $30.16 | $30.16 | $30 | 1,075 | 1,000 | 93.02% |
05-16-2023 | $31.2 | $31.2 | $31.2 | $31.2 | 100 | 100 | 100% |
05-11-2023 | $29.85 | $30.43 | $30.55 | $29.85 | 620 | 300 | 48.39% |
05-10-2023 | $29.85 | $29.85 | $29.85 | $29.85 | 101 | 100 | 99.01% |
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic R/I Ord Company Name:
BVNKF Stock Symbol:
OTCMKTS Market:
Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older is now underway in both the EU and in the U.S. COPENHAGEN, Denmark, June 26, 2024 – Bavarian Nordic ...
First regulatory submission completed for CHIKV VLP seeking approval of the vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older Represents first BLA for a chikungunya vaccine for adolescents COPENHAGEN, Denmark, June 17, 2024...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for i...